DrugListbook

IFU:​ ​Type 1 diabetes mellitus
Route: By injection
Dosage: U-100
Action: lowers blood glucose by stimulating peripheral glucose uptake by skeletal muscle and
fat, and by inhibiting hepatic glucose production.
Adverse​ ​Reaction: Itching, skin rash, wheezing, trouble breathing, fast heart rate, and sweating.
Interactions: Gatifloxacin, tequin, and tequin teqpaq.
Januvia​(Sitagliptin)
Pronunciation: Sit-a-glip-tin
Classification:​ DPP-4 inhibitor​
IFU:​ ​Type 2 diabetes mellitus
Route: Orally
Dosage: 25 mg, 50 mg, and 100 mg.
Action:​ Inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), which slows the inactivation of
incretin hormones, resulting in increased levels of active incretin hormones.
Adverse​ ​Reaction: Headache, pancreatitis, nausea, diarrhea, etc.
Interactions:​ Insulin, glyburide, glipizide, and glimepiride.
Lantus​(Insulin Glargine)
Pronunciation: Glar-gen
Classification:​ insulin​ ​
IFU:​ ​Type 1 diabetes mellitus
Route: By injection
Dosage: 100 units/ml
Action: ​Promotes glucose transport, which stimulates carbohydrate metabolism in skeletal and
cardiac muscle and adipose tissue.
Adverse​ ​Reaction​: urticaria, rash, pruritus, redness, stinging, or warmth at injection site.
Interactions: ​Acetazolamide, albuterol, antiretrovirals, asparaginase, calcitonin, etc.
NovoLog​(Insulin aspart)
Pronunciation: in-su-lin as-spart
Classification:​ ​ insulin
IFU: ​Type 1 diabetes mellitus​
Route: By injection
Dosage: 100 units/ml
Action: Lowers blood glucose by stimulating glucose uptake in skeletal muscle and fat, and
inhibiting hepatic glucose production.
Adverse​ ​Reaction: lipodystrophy, pruritus, erythema, swelling.